Mucosal Leishmaniasis by contiguity with a skin lesion: Another case report from Tunisia;Leishmaniose muqueuse par contiguïté d'une localisation cutanée: À propos d'une nouvelle observation tunisienne

Medecine Tropicale

Volumn 68, Issue 6, 2008, Pages 634-636

  El Fekih N ^a   Sliti, N ^a   Kharfi, M ^a   Trabelsi, S ^b   Khaled, S ^b   Fazaa, B ^a   Kamoun, M R ^a  

^a Service de Dermatologie   (Tunisia)

^b CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Cutaneous Leishmaniasis; Meglumine antimoniate; Mucosal Leishmaniasis; Tunisia

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; ANTIMONY DERIVATIVE; ATOVAQUONE; DAPSONE; IMIDAZOLE; KETOCONAZOLE; MEGLUMINE ANTIMONATE; METRONIDAZOLE; PENTAMIDINE; RIFAMPICIN;

ADULT; ANOREXIA; ARTICLE; BLOOD TOXICITY; CASE REPORT; DIARRHEA; ECG ABNORMALITY; FEMALE; HUMAN; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA TROPICA; LEISHMANIASIS; MYALGIA; NEPHROTOXICITY; NEUTROPENIA; PATHOLOGICAL ANATOMY; SKIN DEFECT; SKIN LEISHMANIASIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUNISIA; VOMITING; ZOONOSIS;

ANTIPROTOZOAL AGENTS; FEMALE; HUMANS; LEISHMANIASIS, MUCOCUTANEOUS; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; TUNISIA;

LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA TROPICA;

EID: 61349190360     PISSN: 0025682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kharfi M, Fazaa B, Chaker E, Kamoun MR. Localisation muqueuse de la leishmaniose en Tunisie: 5 observations. Ann Dermatol Venereal 2003; 130: 27-30.
2. Aoun K, Bouratbine A, Harrat Z, Guizani I, Mokni M, Bel Hadj Ali S et al. Données épidémiologiques et parasitologiques concernant la leishmaniose cutanée sporadique du nord tunisien. Bull Soc Pathol Exot 2000; 93: 101-3.
3. Ben Ismail R, Ben Rachid MS, Gradoni L, Gramiccia M, Helal H, Bach Hamba D. La leishmaniose cutanée zoonotique en Tunisie. Etude du réservoir dans le foyer de Douara. Ann Soc Belge Med Trop 1987; 67: 335-43.
4. Bouratbine A, Aoun K, Ghrab J, Harrat Z, Ezzedini MS, Etlijani S. Spread of Leishmania killicki to Central and South-West Tunisia. Parasite 2005; 12: 59-63.
5. Tomson N, Symonds RP, Moir A.A, Kendall CH, Wiselka MJ. New World leishmaniasis from Spain. Postgrad Med J 2002; 78: 757-8.
6. García de Marcos JA, Dean Ferrer A, Alamillos Granados F, Ruiz-Masera JJ, Cortés Rodriguez B, Vidal Jiménez A et al. Localized Leishmaniasis of the oral mucosa. A report of three cases. Med Oral Patol Oral Cir Bucal 2007; 12: e281-6.
7. Aliaga L, Cobo F, Mediavilla JD, Bravo J, Osuna A, Amador JM et al. Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologie findings in 31 patients. Medicine 2003; 82: 147-58.
8. Del Giudice P, Marty P, Lacour JP. Leishmaniose cutanée autochtone en France métropolitaine. Ann Dermatol Venereol 2001; 128: 1057-62.
9. Ahluwalia S, Lawn SD, Kanagalingam J, Grant H, Lockwood DN. Mucocutaneous leishmaniasis: an imported infection among travellers to central and South America. BMJ 2004; 329: 842-4.
10. Ben Said M., Khaled S, Ben Ismail R, Messedi-Triki S, Khouadja M, Rachid MS. Réponse humorale et leishmaniose cutanée. Bull Soc Fr Parasitol 1987; 5: 187-91.
11. Sastre Pérez J, Muñoz Guerra MF, Naval Gias L, Martin Granizo R, Elices de Apellaniz M, Díaz González FJ. Leishmaniasis oral: A propósito de un caso y revisión de la literatura. Rev Esp drug Oral y Maxilofac 1999; 21: 338-42.
12. Chargui N, Bastien P, Kallel K, Haouas N, Akrout FM, Masmoudi A et al. Usefulness of PCR in the diagnosis of cutaneous leishmaniasis in Tunisia. Trans R Soc Trop Med Hyg 2005; 99: 762-8
13. Buffet P, Caumes E, Gentillini M. Traitement des leishmanioses cutanées localisées. Ann Dermatol Vénéré ol 1994; 121: 503-11
14. Berman JD. Treatment of New World cutaneous and mucosal leishmaniasis. Clin Dermatol 1996; 14: 519-22.
15. Thakur C P, Kumar M, Kumar P, Mishra BN, Pandey AK. Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: A randomised study. Br Med J 1988; 296: 1557-61
16. Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Paris RM. Maguire JH. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 2002; 346: 891-5.
17. Morizot G, Delgiudice P, Caumes E, Laffitte E, Marty P, Dupuy A et al. Healing of old world cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution? Am J Trop Med Hyg 2007; 76: 48-52